Cite
Chen L, Guo Y, Qu S, et al. The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway. Front Pharmacol. 2021;12:619311doi: 10.3389/fphar.2021.619311.
Chen, L., Guo, Y., Qu, S., Li, K., Yang, T., Yang, Y., Zheng, Z., Liu, H., Wang, X., Deng, S., Zhang, Y., Zhu, X., & Li, Y. (2021). The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway. Frontiers in pharmacology, 12619311. https://doi.org/10.3389/fphar.2021.619311
Chen, Lina, et al. "The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway." Frontiers in pharmacology vol. 12 (2021): 619311. doi: https://doi.org/10.3389/fphar.2021.619311
Chen L, Guo Y, Qu S, Li K, Yang T, Yang Y, Zheng Z, Liu H, Wang X, Deng S, Zhang Y, Zhu X, Li Y. The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway. Front Pharmacol. 2021 Mar 08;12:619311. doi: 10.3389/fphar.2021.619311. eCollection 2021. PMID: 33762941; PMCID: PMC7982744.
Copy
Download .nbib